EyePoint Pharmaceuticals Inc. buy Guggenheim
Start price
24.06.26
/
50%
€13.00
Target price
24.06.27
€59.83
Performance (%)
-16.92%
Price
24.07.26
€10.70
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.92%. This prediction currently runs until 24.06.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.727% | -2.727% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Guggenheim for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its "buy" rating reaffirmed by Guggenheim. They now have a $68.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat